EconSight News
Industrial AI
Industrial AI Top Industrial AI Companies: Siemens in the Lead EconSight's contribution at the World Economic Forum in Davos 2026 From a technological perspective, this year's World Economic Forum in Davos is all about AI, especially applications. In our talks, we tried to shift the focus from consumer AI to concrete real-world applications, especially industrial AI. The chart that attracted the most attention was clearly the ranking of the best companies in industrial AI. Contrary to general expectations, Siemens, a European company, leads the way, with Bosch and ABB also in [...]
Top Companies in GenAI
The World of GenAI - Top Companies in Generative AI The World of GenAI - Top Companies in Generative AI The World of GenAI - Top Companies in Generative AI View animation full screen The world of GenAI in one chart – Alphabet leads Tencent and Baidu in world-class GenAI patents The chart shows all companies worldwide with at least four GenAI patents and their development over the past ten years. The colour coding makes clear that GenAI activity [...]
China Tech Focus in new 5-year plan
China technology focus in new 5-year plan for 2026-2030 China position in strategic technologies As part of the recommendations for the next five-year plan, China has outlined its technology priorities for the near future. The technologies themselves are not a big surprise. However, the documents and statements of the last few days reveal a stronger focus on innovation quality. From a patent perspective, this is understandable, which is why we are showing here where China stands in these focus technologies compared to the US and Europe in terms of world-class patents. China is a leader [...]
Genmab after Merus acquisition
Genmab after Merus acquisition Genmab strengthens position among global immunotherapy leaders with Merus acquisition From a patent perspective, the acquisition represents a highly strategic move. Genmab now advances to position 25 among the leading immunotherapy companies, measured by the number of world-class patents. This transaction further strengthens Genmab’s already robust market position. Roche and Bristol Myers Squibb remain industry leaders. When focusing on specialized immunotherapy companies—those with more than half of their patents in this field—the acquisition elevates Genmab into the global top 5, ranking just behind Incyte and BioNTech. For [...]
Deloitte Study
Deloitte-EconSight Study Where does Germany stand in global technology competition? Deloitte and EconSight partnered on a new study The Deloitte study ‘Digital Technologies Made in Germany’ highlights Germany's position in global competition for advanced digitalisation technologies and shows ways in which innovative strength can be strengthened in this country. With a view to the high-tech agenda announced by the German government, this study provides an overview of Germany's position in global technology competition and highlights opportunities and untapped potential, as well as recommendations for action for government stakeholders. Based on [...]
Q&A with EconSight and STOXX
Thematic Investing - Q&A with EconSight and STOXX Q&A with EconSight and STOXX: Navigating the patents landscape in emerging AI technologies In this behind-the-scenes look, you can learn more about how EconSight and STOXX recently teamed up to develop two indices targeting leading companies in specific segments of AI adoption: STOXX Global AI Infrastructure and STOXX Global AI Adopters and Applications. The two indices form the basis for corresponding ETFs from BlackRock iShares. Read the STOXX Blog (external link)
BioNTech and CureVac after takeover
BioNTech and CureVac after takeover BioNTech among top players in mRNA and vaccines after CureVac acquisition The planned acquisition of CureVac announced yesterday makes strategic sense for BioNTech. BioNTech justifies the acquisition with its improved positioning in mRNA technologies. EconSight can confirm this from a patent perspective. In terms of world-class patents in mRNA technologies, BioNTech ranks third after the CureVac acquisition with 141 world-class patents, behind Moderna (252 world-class patents) and 10x Genomics (166 world-class patents). Without a world-class focus, i.e. based [...]
Big Tech Shootout – USA vs China Part II
Big Tech Shootout USA vs China - Pt. 2 - Advanced Digital Technologies The chart shows the technological activities as world shares held by the company in each technology. World share is defined as the share of company world class patents in total global patents in a technology. A bubble position to the right shows a high world share compared to the other companies. US Top-5 tech companies vs. Chinese Top-5 tech companies – advanced digital technologies Microsoft top in a majority of [...]
Big Tech Shootout – USA vs China
Big Tech Shootout USA vs China - Pt. 1 - Human-Machine-Interface Technologies The chart shows the technological activities as world shares held by the company in each technology. World share is defined as the share of company world class patents in total global patents in a technology. A bubble position to the right shows a high world share compared to the other companies. US Top-5 tech companies vs. Chinese Top-5 tech companies – human-machine interface technologies In public debate, big tech companies are often portrayed as a [...]
MarketVector Quantum Computing Index based on EconSight patent insights
MarketVector Quantum Computing Index based on EconSight patent insights MarketVector's Quantum Computing Index based on EconSight’s advanced technology and patent expertise EconSight provided the patent data for MarketVector's Global Quantum Leaders Total Return Net Index. The index is made up of companies primarily focused on the development of quantum computing technology or are leaders in ownership of quantum computing related patents. EconSight has supplied the underlying quantum computing patent technology data with a focus on owners of world-class patents in the technology. This is the basis for the first diversified investment [...]
EconSight QuantumBasel cooperation
EconSight and QuantumBasel – strategic cooperation QuantumBasel and EconSight form strategic partnership to overcome the current limitations of patent analysis QuantumBasel and EconSight are pooling their expertise to take the analysis of highly complex patent data to a new level with the help of AI and quantum computing. The aim: to make hidden correlations in fields of innovation visible and strengthen strategic decisions with data support. Why are patents so important for innovation? Kai Gramke, CEO EconSight: Patents are considered a reliable indicator of a company's innovative activity. The number of patents is growing [...]
Ludwig-Erhard-Summit – Process Technologies
EconSight presented the results from the new study for the Bavarian Industry Association at the Ludwig-Erhard-Summit, the «Geman Davos» in May 2025. This study uses patent analysis to examine global research activities in key process technologies and their significance for major future technology fields. The results highlight the technological leadership of China, the United States and Japan. Germany is well positioned but needs to gain momentum in order to remain competitive internationally. The video is in German but you can activate sub-titles in your language. More informaton and download of the study [...]
Industrial AI
Industrial AI Top Industrial AI Companies: Siemens in the Lead EconSight's contribution at the World Economic Forum in Davos 2026 From a technological perspective, this year's World Economic Forum in Davos is all about AI, especially applications. In our talks, we tried to shift the focus from consumer AI to concrete real-world applications, especially industrial AI. The chart that attracted the most attention was clearly the ranking of the best companies in industrial AI. Contrary to general expectations, Siemens, a European company, leads the way, with Bosch and ABB also in [...]
Top Companies in GenAI
The World of GenAI - Top Companies in Generative AI The World of GenAI - Top Companies in Generative AI The World of GenAI - Top Companies in Generative AI View animation full screen The world of GenAI in one chart – Alphabet leads Tencent and Baidu in world-class GenAI patents The chart shows all companies worldwide with at least four GenAI patents and their development over the past ten years. The colour coding makes clear that GenAI activity [...]
China Tech Focus in new 5-year plan
China technology focus in new 5-year plan for 2026-2030 China position in strategic technologies As part of the recommendations for the next five-year plan, China has outlined its technology priorities for the near future. The technologies themselves are not a big surprise. However, the documents and statements of the last few days reveal a stronger focus on innovation quality. From a patent perspective, this is understandable, which is why we are showing here where China stands in these focus technologies compared to the US and Europe in terms of world-class patents. China is a leader [...]
Genmab after Merus acquisition
Genmab after Merus acquisition Genmab strengthens position among global immunotherapy leaders with Merus acquisition From a patent perspective, the acquisition represents a highly strategic move. Genmab now advances to position 25 among the leading immunotherapy companies, measured by the number of world-class patents. This transaction further strengthens Genmab’s already robust market position. Roche and Bristol Myers Squibb remain industry leaders. When focusing on specialized immunotherapy companies—those with more than half of their patents in this field—the acquisition elevates Genmab into the global top 5, ranking just behind Incyte and BioNTech. For [...]
Deloitte Study
Deloitte-EconSight Study Where does Germany stand in global technology competition? Deloitte and EconSight partnered on a new study The Deloitte study ‘Digital Technologies Made in Germany’ highlights Germany's position in global competition for advanced digitalisation technologies and shows ways in which innovative strength can be strengthened in this country. With a view to the high-tech agenda announced by the German government, this study provides an overview of Germany's position in global technology competition and highlights opportunities and untapped potential, as well as recommendations for action for government stakeholders. Based on [...]
Q&A with EconSight and STOXX
Thematic Investing - Q&A with EconSight and STOXX Q&A with EconSight and STOXX: Navigating the patents landscape in emerging AI technologies In this behind-the-scenes look, you can learn more about how EconSight and STOXX recently teamed up to develop two indices targeting leading companies in specific segments of AI adoption: STOXX Global AI Infrastructure and STOXX Global AI Adopters and Applications. The two indices form the basis for corresponding ETFs from BlackRock iShares. Read the STOXX Blog (external link)
BioNTech and CureVac after takeover
BioNTech and CureVac after takeover BioNTech among top players in mRNA and vaccines after CureVac acquisition The planned acquisition of CureVac announced yesterday makes strategic sense for BioNTech. BioNTech justifies the acquisition with its improved positioning in mRNA technologies. EconSight can confirm this from a patent perspective. In terms of world-class patents in mRNA technologies, BioNTech ranks third after the CureVac acquisition with 141 world-class patents, behind Moderna (252 world-class patents) and 10x Genomics (166 world-class patents). Without a world-class focus, i.e. based [...]
Big Tech Shootout – USA vs China Part II
Big Tech Shootout USA vs China - Pt. 2 - Advanced Digital Technologies The chart shows the technological activities as world shares held by the company in each technology. World share is defined as the share of company world class patents in total global patents in a technology. A bubble position to the right shows a high world share compared to the other companies. US Top-5 tech companies vs. Chinese Top-5 tech companies – advanced digital technologies Microsoft top in a majority of [...]
Big Tech Shootout – USA vs China
Big Tech Shootout USA vs China - Pt. 1 - Human-Machine-Interface Technologies The chart shows the technological activities as world shares held by the company in each technology. World share is defined as the share of company world class patents in total global patents in a technology. A bubble position to the right shows a high world share compared to the other companies. US Top-5 tech companies vs. Chinese Top-5 tech companies – human-machine interface technologies In public debate, big tech companies are often portrayed as a [...]
MarketVector Quantum Computing Index based on EconSight patent insights
MarketVector Quantum Computing Index based on EconSight patent insights MarketVector's Quantum Computing Index based on EconSight’s advanced technology and patent expertise EconSight provided the patent data for MarketVector's Global Quantum Leaders Total Return Net Index. The index is made up of companies primarily focused on the development of quantum computing technology or are leaders in ownership of quantum computing related patents. EconSight has supplied the underlying quantum computing patent technology data with a focus on owners of world-class patents in the technology. This is the basis for the first diversified investment [...]
EconSight QuantumBasel cooperation
EconSight and QuantumBasel – strategic cooperation QuantumBasel and EconSight form strategic partnership to overcome the current limitations of patent analysis QuantumBasel and EconSight are pooling their expertise to take the analysis of highly complex patent data to a new level with the help of AI and quantum computing. The aim: to make hidden correlations in fields of innovation visible and strengthen strategic decisions with data support. Why are patents so important for innovation? Kai Gramke, CEO EconSight: Patents are considered a reliable indicator of a company's innovative activity. The number of patents is growing [...]
Ludwig-Erhard-Summit – Process Technologies
EconSight presented the results from the new study for the Bavarian Industry Association at the Ludwig-Erhard-Summit, the «Geman Davos» in May 2025. This study uses patent analysis to examine global research activities in key process technologies and their significance for major future technology fields. The results highlight the technological leadership of China, the United States and Japan. Germany is well positioned but needs to gain momentum in order to remain competitive internationally. The video is in German but you can activate sub-titles in your language. More informaton and download of the study [...]